|
Antivirals key to MAC prevention regimen. |
1996 |
AIDS Alert |
pmid:11363722
|
Torres G |
MAC prophylaxis revisited. |
1996 |
GMHC Treat Issues |
pmid:11363706
|
|
Old drug approved for MAC prevention. |
1996 |
AIDS Alert |
pmid:11363659
|
Currier J |
Progress report: prophylaxis and therapy for MAC. |
1996 |
AIDS Clin Care |
pmid:11363599
|
Prescott LM |
Macrolides, azalides, and streptogrammins. |
1996 |
J Int Assoc Physicians AIDS Care |
pmid:11363516
|
Cheng B |
Advances in prevention and treatment of MAC. |
1995 |
PI Perspect |
pmid:11363104
|
|
Rifabutin for MAC questioned. |
1995 Jul-Aug |
Posit Aware |
pmid:11362571
|
|
What's in the water? |
1995 Mar-Apr |
Treat Rev |
pmid:11362299
|
Benson C |
Advances in the diagnosis and treatment of Mycobacterium avium complex (MAC) disease. |
1994 |
AIDS Patient Care |
pmid:11362136
|
|
Azithromycin and OIs. |
1996 |
AIDS Patient Care STDS |
pmid:11361699
|
|
Prophylactic antibiotic receives speedy FDA approval to reduce MAC disease in advanced HIV. |
1996 |
AIDS Patient Care STDS |
pmid:11361569
|
|
Clearance to market azithromycin as prevention for a common OI in advanced AIDS. |
1996 |
AIDS Patient Care STDS |
pmid:11361535
|
Fang X et al. |
[Inhibitory activity of azithromycin on biofilm synthesis and synergism between azithromycin and fleroxacin on Pseudomonas aeruginosa in biofilms]. |
1998 |
Zhonghua Jie He He Hu Xi Za Zhi |
pmid:11360505
|
Kaplan EL et al. |
Macrolide therapy of group A streptococcal pharyngitis: 10 days of macrolide therapy (clarithromycin) is more effective in streptococcal eradication than 5 days (azithromycin). |
2001 |
Clin. Infect. Dis. |
pmid:11360224
|
St Clair EW et al. |
The effects of intravenous doxycycline therapy for rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. |
2001 |
Arthritis Rheum. |
pmid:11357896
|
Dinos GP et al. |
Insights into the mechanism of azithromycin interaction with an Escherichia coli functional ribosomal complex. |
2001 |
Mol. Pharmacol. |
pmid:11353804
|
Tateda K et al. |
Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11353657
|
Littler WA |
Clindamycin suspension and endocarditis prophylaxis. |
2001 |
Br Dent J |
pmid:11352383
|
Akritopoulou-Zanze I and Sowin TJ |
Solid-phase synthesis of macrolide analogues. |
2001 May-Jun |
J Comb Chem |
pmid:11350254
|
Bowden FJ et al. |
Azithromycin and pelvic inflammatory disease in the Northern Territory. |
2001 |
Med. J. Aust. |
pmid:11346115
|
Westfall DS et al. |
Inoculation of two genotypes of Hemobartonella felis (California and Ohio variants) to induce infection in cats and the response to treatment with azithromycin. |
2001 |
Am. J. Vet. Res. |
pmid:11341386
|
Tan JS et al. |
Persistently positive culture results in a patient with community-acquired pneumonia due to Legionella pneumophila. |
2001 |
Clin. Infect. Dis. |
pmid:11340527
|
Griffith DE et al. |
Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease. |
2001 |
Clin. Infect. Dis. |
pmid:11340525
|
Stein GE and Schooley S |
Comparative serum bactericidal activity of clarithromycin and azithromycin against macrolide-sensitive and resistant strains of Streptococcus pneumoniae. |
2001 |
Diagn. Microbiol. Infect. Dis. |
pmid:11337186
|
Samra Z et al. |
In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines. |
2001 |
Diagn. Microbiol. Infect. Dis. |
pmid:11337185
|
RodrÃguez Núñez A et al. |
[Chemoprophylaxis of meningococcal disease with azithromycin and ciprofloxacin]. |
2001 |
An. Esp. Pediatr. |
pmid:11333489
|
Skerk V et al. |
Duration of clinical symptoms in female patients with acute urethral syndrome caused by Chlamydia trachomatis treated with azithromycin or doxycycline. |
2001 |
J Chemother |
pmid:11330365
|
Zarantonelli L et al. |
Decreased susceptibility to azithromycin and erythromycin mediated by a novel mtr(R) promoter mutation in Neisseria gonorrhoeae. |
2001 |
J. Antimicrob. Chemother. |
pmid:11328778
|
Gupta S et al. |
Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study. |
2001 |
Clin Ther |
pmid:11318079
|
Kays MB and Denys GA |
In vitro activity and pharmacodynamics of azithromycin and clarithromycin against Streptococcus pneumoniae based on serum and intrapulmonary pharmacokinetics. |
2001 |
Clin Ther |
pmid:11318076
|
Jacobson JM et al. |
Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS. |
2001 |
AIDS |
pmid:11316995
|
Lechner A and Bruckner DA |
Oligella ureolytica in blood culture: contaminant or infection? |
2001 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:11305472
|
Elewski BE |
A novel treatment for acne vulgaris and rosacea. |
2000 |
J Eur Acad Dermatol Venereol |
pmid:11305392
|
Powell FC |
What's going on in rosacea? |
2000 |
J Eur Acad Dermatol Venereol |
pmid:11305376
|
Hafner R et al. |
Tolerance and pharmacokinetic interactions of rifabutin and azithromycin. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11302832
|
Treadway G |
Azithromycin: a new 15-membered macrolide. |
2001 |
Jpn J Antibiot |
pmid:11296412
|
Sorvillo F et al. |
Incidence and determinants of Pseudomonas aeruginosa infection among persons with HIV: association with hospital exposure. |
2001 |
Am J Infect Control |
pmid:11287873
|
Bailey R and Lietman T |
The SAFE strategy for the elimination of trachoma by 2020: will it work? |
2001 |
Bull. World Health Organ. |
pmid:11285668
|
Frick KD et al. |
Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children. |
2001 |
Bull. World Health Organ. |
pmid:11285663
|
Holm SO et al. |
Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal. |
2001 |
Bull. World Health Organ. |
pmid:11285662
|
Waring AL et al. |
Development of a genomics-based PCR assay for detection of Mycoplasma pneumoniae in a large outbreak in New York State. |
2001 |
J. Clin. Microbiol. |
pmid:11283060
|
Parsad D et al. |
Azithromycin monthly pulse vs daily doxycycline in the treatment of acne vulgaris. |
2001 |
J. Dermatol. |
pmid:11280457
|
Gulati R et al. |
Comparative bioavailability of two formulations of azithromycin. |
2000 |
J Assoc Physicians India |
pmid:11273540
|
Bharat V and Mohanty B |
Bleeding complication during coumarin therapy due to amiodarone and azithromycin. |
2000 |
J Assoc Physicians India |
pmid:11273517
|
Butler T et al. |
In vitro effects of azithromycin on Salmonella typhi: early inhibition by concentrations less than the MIC and reduction of MIC by alkaline pH and small inocula. |
2001 |
J. Antimicrob. Chemother. |
pmid:11266420
|
Ferwerda A et al. |
Efficacy, safety and tolerability of 3 day azithromycin versus 10 day co-amoxiclav in the treatment of children with acute lower respiratory tract infections. |
2001 |
J. Antimicrob. Chemother. |
pmid:11266417
|
Graybill JR and Bocanegra R |
Treatment alternatives for Mycobacterium kansasii. |
2001 |
J. Antimicrob. Chemother. |
pmid:11266413
|
Grand A et al. |
[Subacute infectious endocarditis due to the agent of cat scratch fever: Bartonella henselae]. |
2001 |
Arch Mal Coeur Vaiss |
pmid:11265556
|
Lietman T and Fry A |
Can we eliminate trachoma? |
2001 |
Br J Ophthalmol |
pmid:11264123
|
Baumann U et al. |
Buccal adherence of Pseudomonas aeruginosa in patients with cystic fibrosis under long-term therapy with azithromycin. |
2001 Jan-Feb |
Infection |
pmid:11261763
|